Expressions of SIRT6 and survivin in gastric cancer tissue and their clinical significances
10.3760/cma.j.cn371439-20191230-00005
- VernacularTitle:SIRT6和survivin在胃癌组织中的表达及其临床意义
- Author:
Ying WANG
1
;
Wei YANG
;
Juxiang XIAO
Author Information
1. 西安交通大学第一附属医院干部保健办公室 710061
- From:
Journal of International Oncology
2020;47(4):217-222
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To discuss the relationships between the expressions of silence information regulator 6 (SIRT6) and survivin and clinicopathological features of gastric cancer, and to investigate their effects in gastric cancer.Methods:The tumor tissues of 110 gastric cancer patients admitted to the First Affiliated Hospital of Xi′an Jiaotong University from March 2013 to October 2014, as well as 40 adjacent tissues and 20 normal tissues, were selected to detect the expressions of SIRT6 and survivin by immunohistochemistry. The correlations between the expression levels of SIRT6 and survivin and the clinicopathological features and prognosis of gastric cancer patients were analyzed.Results:The positive rates of SIRT6 were 41.8% (46/110), 77.5% (31/40) and 85.0% (17/20) in gastric cancer, adjacent tissues and normal gastric tissues, respectively, and the difference among the three groups was statistically significant ( χ2=23.200, P<0.001). The positive rate of SIRT6 in gastric cancer tissue was lower than that in adjacent and normal tissues ( χ2=14.949, P<0.001; χ2=12.634, P<0.001). The expression of SIRT6 was correlated with tumor differentiation ( χ2=19.654, P<0.001). The positive rates of survivin were 58.2% (64/110), 15.0% (6/40) and 0 (0/20) in gastric cancer, adjacent tissues and normal gastric tissues, respectively, and the difference among the three groups was statistically significant ( χ2=38.449, P<0.001). The positive rate of survivin in gastric cancer tissue was higher than that in adjacent and normal tissues ( χ2=21.976, P<0.001; χ2=22.920, P<0.001). The expression of survivin was correlated with the depth of infiltration ( χ2=20.853, P<0.001). The expression of SIRT6 was correlated with survivin in gastric cancer tissues ( C=0.211, P=0.024). Survival analysis showed that 3-year survival rate was 53.1% in the SIRT6 negative patients, lower than 78.3% in the positive patients, and the difference was statistically significant ( χ2=4.004, P=0.045), while the 3-year survival rates of the survivin positive and negative patients were 53.1% and 78.3%, and the difference was not significant ( χ2=3.717, P=0.054). Cox multivariate regression analysis showed that lymph node metastasis ( RR=6.618, 95% CI: 2.152-20.358, P=0.001) and SIRT6 negative expression ( RR=0.228, 95% CI: 0.081-0.644, P=0.005) were the risk factors for poor prognosis of gastric cancer. Conclusion:SIRT6 is poorly expressed in gastric cancer tissues and is related to the prognosis of gastric cancer, while survivin is highly expressed in gastric cancer tissues. The expression of SIRT6 and survivin is negatively correlated, suggesting that the expression imbalance of SIRT6 and survivin may play an important role in the occurrence and development of gastric cancer.
